Roles of dopamine receptor subtypes in mediating modulation of T lymphocyte function

Neuroendocrinology Letters

Volumn 31, Issue 6, 2010, Pages 782-791

  Huang, Yan ^a   Qiu, Ao Wang ^b   Peng, Yu Ping ^a   Liu, Yan ^a   Huang, Hui Wei ^a   Qiu, Yi Hua ^a  

^a NANTONG MEDICAL COLLEGE   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

cAMP; CREB; Dopamine D1 like receptors; Dopamine D2 like receptors; T lymphocytes

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; CONCANAVALIN A; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE 5 RECEPTOR; GAMMA INTERFERON; HALOPERIDOL; INTERLEUKIN 4; MESSENGER RNA; QUINPIROLE; RECEPTOR SUBTYPE;

ANIMAL CELL; ARTICLE; COLORIMETRY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOMETRY; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; WESTERN BLOTTING;

EID: 79751523106     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Abbas AK, Murphy KM, Sher A (1996). Functional diversity of helper T lymphocytes. Nature. 383: 787-793.
2. Bao JY, Huang Y, Wang F, et al (2007). Expression of α-AR subtypes in T lymphocytes and role of the α-ARs in mediating modulation of T cell function. Neuroimmunomodulation. 14: 344-353. (Pubitemid 351737863)
3. Basu S, Dasgupta PS (2000). Dopamine, a neurotransmitter, influences the immune system. J. Neuroimmunol. 102: 113-124.
4. Beck G, Brinkkoetter P, Hanusch C, et al (2004). Clinical review: Immunomodulatory effects of dopamine in general inflammation. Crit. Care. 8: 485-491.
5. Beck G, Hanusch C, Brinkkoetter P, et al (2005). Effects of dopamine on cellular and humoral immune responses in septic patients. Anaesthesist. 54: 1012-1020. (Pubitemid 41577432)
6. Bergquist J, Josefsson E, Tarkowski A, et al (1997). Measurements of catecholamine-mediated apoptosis of immunocompetent cells by capillary electrophoresis. Electrophoresis. 18: 1760-1766. (Pubitemid 27451830)
7. Bergquist J, Tarkowski A, Ewing A, et al (1998). Catecholaminergic suppression of immunocompetent cells. Immunol. Today. 19: 562-567.
8. Bertram EM, Jilbert AR, Kotlarski L (1997). Optimization of an in vitro assay which measures the proliferation of duck T lymphocytes from peripheral blood in response to stimulation with PHA and Con A. Dev. Comp. Immunol. 21: 299-310.
9. Besser MJ, Ganor Y, Levite M (2005). Dopamine by itself activates either D2, D3 or D1/D5 dopaminergic receptors in normal human T cells and triggers the selective secretion of either IL-10, TNFα or both. J. Neuroimmunol. 169: 161-171. (Pubitemid 41528789)
10. Bondy B, de Jonge S, Pander S, et al (1996). Ackenheil M. Identification of dopamine D4 receptor mRNA in circulating human lymphocytes using nested polymerase chain reaction. J. Neuroimmunol. 71: 139-144.
11. Buckley AF, Kuo CT, Leiden JM (2001). Transcription factor LKLF is sufficient to program T cell quiescence via a c-Myc-dependent pathway. Nat. Immunol. 2: 698-704.
12. Caronti B, Calderaro C, Passarelli F, et al (1998). Dopamine receptor mRNAs in the rat lymphocytes. Life Sci. 62: 1919-1925.
13. Carr L, Tucker A, Fernandez-Botran R (2003). In vivo administration of L-dopa or dopamine decreases the number of splenic IFNγ-producing cells. J. Neuroimmunol. 137: 87-93.
14. Choi EJ, Xia Z, Villacres EC, et al (1993). The regulatory diversity of the mammalian adenylyl cyclases. Curr. Opin. Cell Biol. 5: 269-273.
15. Cioca DP, Watanabe N, Isobe M (2000). Apoptosis of peripheral blood lymphocytes is induced by catecholamines. Jpn. Heart J. 41: 385-398.
16. Cook-Mills JM, Cohen RL, Perlman RL, et al (1995). Inhibition of lymphocyte activation by catecholamines: evidence for a non classical mechanism of catecholamine action. Immunology. 4: 544-549.
17. Fearon DT, Locksley RM (1996). The instructive role of innate immunity in the acquired immune response. Science. 272: 50-53.
18. Fikri Y, Nyabenda J, Denis M, et al (2000). Purification and characterisation of bovine WC1+ γδ T lymphocytes from peripheral blood. Vet. Res. 31: 229-239.
19. Ghosh MC, Mondai AC, Basu S, et al (2003). Dopamine inhibits cytokine release and expression of tyrosine kinases, Lck and Fyn in activated T cells. Int. Immunopharmacol. 3: 1019-1026.
20. Greaves MF, Brown G (1974). Purification of human T and B lymphocytes. J. Immunol. 112: 420-423.
21. Hansen MB, Nielsen SE, Berg K (1989). Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods. 119: 203-210.
22. 2+ channel diversity. Annu. Rev. Neurosci. 17: 399-418.
23. Ilani T, Strous RD, Fuchs S (2004). Dopaminergic regulation of immune cells via D3 dopamine receptor: a pathway mediated by activated T cells. FASEB J. 18: 1600-1602. (Pubitemid 39561646)
24. Jackson DM, Westlind-Danielsson A (1994). Dopamine receptors: molecular biology, biochemistry and behavioural aspects. Pharmacol. Ther. 64: 291-370.
25. Josefsson E, Bergquist J, Ekman R, et al (1996). Catecholamines are synthesized by mouse lymphocytes and regulate function of these cells by induction of apoptosis. Immunology. 88: 140-146. (Pubitemid 26166387)
26. Lee MY, Heo JS, Han HJ (2006). Dopamine regulates cell cycle regulatory proteins via cAMP, Ca(2+)/PKC, MAPKs, and NF-kappaB in mouse embryonic stem cells. J. Cell. Physiol. 208: 399-406.
27. Levite M (2008). Neurotransmitters activate T cells and elicit crucial functions via neurotransmitter receptors. Curr. Opin. Pharmacol. 8: 460-471.
28. Maestroni GJ (2006). Sympathetic nervous system influence on the innate immune response. Ann. N.Y. Acad. Sci. 1069: 195-207.
29. McKenna F, McLaughlin PJ, Lewis BJ, et al (2002). Dopamine receptor expression on human T- and B-lymphocytes, monocytes, neutrophils, eosinophils and NK cells: a flow cytometric study. J. Neuroimmunol. 132: 34-40. (Pubitemid 35333323)
30. Monsma Jr FJ, Mahan LC, McVittie LD, et al (1990). Molecular cloning and expression of a D1 dopamine receptor linked to adenylyl cyclase activation. Proc. Natl. Acad. Sci. USA. 87: 6723-6727.
31. Montminy MR, Bilezikjian LM (1987). Binding of a nuclear protein to the cyclic-AMP response element of the somatostatin gene: Nature. 328: 175-178.
32. Morikawa K, Oseko F, Morikawa S (1993). Immunosuppressive property of bromocriptine on human B lymphocyte function in vitro. Clin. Exp. Immunol. 93: 200-205.
33. Morikawa K, Oseko F, Morikawa S (1994). Immunosuppressive activity of bromocriptine on human T lymphocyte function in vitro. Clin. Exp. Immunol. 95: 514-518.
34. Mosmann TR, Sad S (1996). The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today. 17: 138-146.
35. Offen D, Ziv I, Gorodins S, et al (1995). Dopamine-induced programmed cell death in mouse thymocytes. Biochim. Biophys. Acta. 268: 171-177.
36. Pacheco R, Prado CE, Barrientos MJ, et al (2009). Role of dopamine in the physiology of T cells and dendritic cells. J. Neuroimmunol. 216: 8-19.
37. Pesić V, Plećas-Solarović B, Radojević K, et al (2007). Long-term beta-adrenergic receptor blockade increases levels of the most mature thymocyte subsets in aged rats. Int. Immunopharmacol. 7: 674-686.
38. Platzer C, Docke W, Volk H, et al (2000). Catecholamines trigger IL-10 release in acute systemic stress reaction by direct stimulation of its promoter/enhancer activity in monocytic cells. J. Neuroimmunol. 105: 31-38. (Pubitemid 30125426)
39. Ricci A, Bronzetti E, Mignini F, et al (1999). Dopamine D1-like receptor subtypes in human peripheral blood lymphocytes. J. Neuroimmunol. 96: 234-240. (Pubitemid 29234498)
40. Rohr O, Sawaya BE, Lecestre D, et al (1999). Dopamine stimulates expression of the human immunodeficiency virus type 1 via NF-κB in cells of the immune system. Nucleic. Acids Res. 27: 3291-3299.
41. Saha B, Mondal AC, Basu S, et al (2001a). Circulating dopamine level, in lung carcinoma patients, inhibits proliferation and cytotoxicity of CD4+ and CD8+ T cells by D1 dopamine receptors: an in vitro analysis. Int. Immunopharmacol. 1: 1363-1374.
42. Saha B, Mondal AC, Majumder J, et al (2001b). Physiological concentration of dopamine inhibits the proliferation and cytotoxicity of CD4+ and CD8+ T lymphocytes in vitro: a receptor mediated mechanism. Neuroimmunomodulation. 9: 23-33.
43. Sarchielli P, Di Filippo M, Candeliere A, et al (2007). Expression of ionotropic glutamate receptor GLUR3 and effects of glutamate on MBP and MOG-specific lymphocyte activation and chemotactic migration in multiple sclerosis patients. J Neuroimmunol. 188: 146-158. (Pubitemid 47095024)
44. Sarkar C, Das S, Chakroborty D, et al (2006). Cutting edge: stimulation of dopamine D4 receptors induce T cell quiescence by upregulating Kruppel-like factor-2 expression through inhibition of ERK1/ERK2 phosphorylation. J. Immunol. 177: 7525-7529. (Pubitemid 44846267)
45. Sibley DR, Monsma Jr FJ, Shen Y (1993). Molecular neurobiology of dopaminergic receptors. Int. Rev. Neurobiol. 35: 391-415.
46. Sunahara RK, Guan HC, O'Dowd BF, et al (1991). Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1. Nature. 350: 614-619. (Pubitemid 21912283)
47. Tsao CW, Lin YS, Cheng JT (1997). Effect of dopamine on immune cell proliferation in mice. Life Sci. 61: 361-371.
48. Vallone D, Picetti R, Borrelli E (2000). Structure and function of dopamine receptors. Neurosci. Biobehav. Rev. 24: 125-132.
49. Wohlera JE, Barnum SR (2009). Nylon wool purification alters the activation of T cells. Mol. Immunol. 46: 1007-1010.
50. Yao WD, Spealman RD, Zhang J (2008). Dopaminergic Signaling in Dendritic Spines. Biochem. Pharmacol. 75: 2055-2069.
51. Yasunari K, Kohno M, Kano H, et al (1999). Anti-atherosclerotic action of vascular D1 receptors. Clin. Exp. Pharmacol. Physiol. 26: S36-40.
52. Yin J, Albert RH, Tretiakova AP, et al (2006). 5-HT(1B) receptors play a prominent role in the proliferation of T-lymphocytes. J. Neuroimmunol. 181: 68-81. (Pubitemid 44827291)